Global Point-of-care Testing (POCT) for Substance Abuse Market Research Report 2025(Status and Outlook)
Report Overview
Point-of-care Testing (POCT) for Substance Abuse refers to a category of medical diagnostic tests that are designed to provide rapid results for the detection of various substances of abuse directly at the patient's side or near the patient. These tests are typically performed outside of a traditional laboratory setting, such as in emergency departments, physician offices, or rehabilitation centers. The primary goal of POCT for substance abuse is to enable healthcare professionals to quickly identify the presence of drugs or alcohol in a patient's system, which can aid in the diagnosis, treatment, and management of substance abuse disorders. The tests are often based on immunoassay technology and can detect a wide range of substances, including opioids, amphetamines, cocaine, marijuana, and alcohol. The convenience and speed of POCT for substance abuse make it a valuable tool for immediate clinical decision-making and patient care.
This report provides a deep insight into the global Point-of-care Testing (POCT) for Substance Abuse market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Point-of-care Testing (POCT) for Substance Abuse Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Point-of-care Testing (POCT) for Substance Abuse market in any manner.
Global Point-of-care Testing (POCT) for Substance Abuse Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Danaher
Abbott
Siemens
Beijing Hotgen Biotech
Hangzhou Biotest Biotech CO.,LTD
Assure Tech
Orient Gene
Thermo Fisher
Guangzhou Wondfo Biotech Co.,Ltd.
Hangzhou Alltest Biotech Co.,Ltd.
Beckman Coulter
Bio-Rad
BioMerieux
Market Segmentation (by Type)
Based on Colloidal Gold
Based on Fluorescence Immunochromatography
Market Segmentation (by Application)
Hospital
Diagnostic Center
Road Traffic Safety
Military
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Point-of-care Testing (POCT) for Substance Abuse Market
Overview of the regional outlook of the Point-of-care Testing (POCT) for Substance Abuse Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Point-of-care Testing (POCT) for Substance Abuse Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Point-of-care Testing (POCT) for Substance Abuse, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Point-of-care Testing (POCT) for Substance Abuse refers to a category of medical diagnostic tests that are designed to provide rapid results for the detection of various substances of abuse directly at the patient's side or near the patient. These tests are typically performed outside of a traditional laboratory setting, such as in emergency departments, physician offices, or rehabilitation centers. The primary goal of POCT for substance abuse is to enable healthcare professionals to quickly identify the presence of drugs or alcohol in a patient's system, which can aid in the diagnosis, treatment, and management of substance abuse disorders. The tests are often based on immunoassay technology and can detect a wide range of substances, including opioids, amphetamines, cocaine, marijuana, and alcohol. The convenience and speed of POCT for substance abuse make it a valuable tool for immediate clinical decision-making and patient care.
This report provides a deep insight into the global Point-of-care Testing (POCT) for Substance Abuse market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Point-of-care Testing (POCT) for Substance Abuse Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Point-of-care Testing (POCT) for Substance Abuse market in any manner.
Global Point-of-care Testing (POCT) for Substance Abuse Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Roche
Danaher
Abbott
Siemens
Beijing Hotgen Biotech
Hangzhou Biotest Biotech CO.,LTD
Assure Tech
Orient Gene
Thermo Fisher
Guangzhou Wondfo Biotech Co.,Ltd.
Hangzhou Alltest Biotech Co.,Ltd.
Beckman Coulter
Bio-Rad
BioMerieux
Market Segmentation (by Type)
Based on Colloidal Gold
Based on Fluorescence Immunochromatography
Market Segmentation (by Application)
Hospital
Diagnostic Center
Road Traffic Safety
Military
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Point-of-care Testing (POCT) for Substance Abuse Market
Overview of the regional outlook of the Point-of-care Testing (POCT) for Substance Abuse Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Point-of-care Testing (POCT) for Substance Abuse Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Point-of-care Testing (POCT) for Substance Abuse, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Point-of-care Testing (POCT) for Substance Abuse
1.2 Key Market Segments
1.2.1 Point-of-care Testing (POCT) for Substance Abuse Segment by Type
1.2.2 Point-of-care Testing (POCT) for Substance Abuse Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Point-of-care Testing (POCT) for Substance Abuse Product Life Cycle
3.3 Global Point-of-care Testing (POCT) for Substance Abuse Sales by Manufacturers (2020-2025)
3.4 Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Manufacturers (2020-2025)
3.5 Point-of-care Testing (POCT) for Substance Abuse Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Point-of-care Testing (POCT) for Substance Abuse Market Competitive Situation and Trends
3.8.1 Point-of-care Testing (POCT) for Substance Abuse Market Concentration Rate
3.8.2 Global 5 and 10 Largest Point-of-care Testing (POCT) for Substance Abuse Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE INDUSTRY CHAIN ANALYSIS
4.1 Point-of-care Testing (POCT) for Substance Abuse Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Point-of-care Testing (POCT) for Substance Abuse Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Point-of-care Testing (POCT) for Substance Abuse Market
5.7 ESG Ratings of Leading Companies
6 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2020-2025)
6.3 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Type (2020-2025)
6.4 Global Point-of-care Testing (POCT) for Substance Abuse Price by Type (2020-2025)
7 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Sales by Application (2020-2025)
7.3 Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) by Application (2020-2025)
7.4 Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate by Application (2020-2025)
8 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET SALES BY REGION
8.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region
8.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region
8.3 North America
8.3.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales by Country
8.3.2 North America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country
8.4.2 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.5.2 Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales by Country
8.6.2 South America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.7.2 Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET PRODUCTION BY REGION
9.1 Global Production of Point-of-care Testing (POCT) for Substance Abuse by Region(2020-2025)
9.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2020-2025)
9.3 Global Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Point-of-care Testing (POCT) for Substance Abuse Production
9.4.1 North America Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.4.2 North America Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Point-of-care Testing (POCT) for Substance Abuse Production
9.5.1 Europe Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.5.2 Europe Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Point-of-care Testing (POCT) for Substance Abuse Production (2020-2025)
9.6.1 Japan Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.6.2 Japan Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Point-of-care Testing (POCT) for Substance Abuse Production (2020-2025)
9.7.1 China Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.7.2 China Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Danaher
10.2.1 Danaher Basic Information
10.2.2 Danaher Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.2.4 Danaher Business Overview
10.2.5 Danaher SWOT Analysis
10.2.6 Danaher Recent Developments
10.3 Abbott
10.3.1 Abbott Basic Information
10.3.2 Abbott Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.3.4 Abbott Business Overview
10.3.5 Abbott SWOT Analysis
10.3.6 Abbott Recent Developments
10.4 Siemens
10.4.1 Siemens Basic Information
10.4.2 Siemens Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.4.4 Siemens Business Overview
10.4.5 Siemens Recent Developments
10.5 Beijing Hotgen Biotech
10.5.1 Beijing Hotgen Biotech Basic Information
10.5.2 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.5.4 Beijing Hotgen Biotech Business Overview
10.5.5 Beijing Hotgen Biotech Recent Developments
10.6 Hangzhou Biotest Biotech CO.,LTD
10.6.1 Hangzhou Biotest Biotech CO.,LTD Basic Information
10.6.2 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.6.4 Hangzhou Biotest Biotech CO.,LTD Business Overview
10.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments
10.7 Assure Tech
10.7.1 Assure Tech Basic Information
10.7.2 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.7.4 Assure Tech Business Overview
10.7.5 Assure Tech Recent Developments
10.8 Orient Gene
10.8.1 Orient Gene Basic Information
10.8.2 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.8.4 Orient Gene Business Overview
10.8.5 Orient Gene Recent Developments
10.9 Thermo Fisher
10.9.1 Thermo Fisher Basic Information
10.9.2 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.9.4 Thermo Fisher Business Overview
10.9.5 Thermo Fisher Recent Developments
10.10 Guangzhou Wondfo Biotech Co.,Ltd.
10.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Basic Information
10.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
10.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
10.11 Hangzhou Alltest Biotech Co.,Ltd.
10.11.1 Hangzhou Alltest Biotech Co.,Ltd. Basic Information
10.11.2 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.11.4 Hangzhou Alltest Biotech Co.,Ltd. Business Overview
10.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments
10.12 Beckman Coulter
10.12.1 Beckman Coulter Basic Information
10.12.2 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.12.4 Beckman Coulter Business Overview
10.12.5 Beckman Coulter Recent Developments
10.13 Bio-Rad
10.13.1 Bio-Rad Basic Information
10.13.2 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.13.4 Bio-Rad Business Overview
10.13.5 Bio-Rad Recent Developments
10.14 BioMerieux
10.14.1 BioMerieux Basic Information
10.14.2 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.14.4 BioMerieux Business Overview
10.14.5 BioMerieux Recent Developments
11 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET FORECAST BY REGION
11.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast
11.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country
11.2.3 Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region
11.2.4 South America Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Point-of-care Testing (POCT) for Substance Abuse by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Point-of-care Testing (POCT) for Substance Abuse by Type (2026-2033)
12.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Point-of-care Testing (POCT) for Substance Abuse by Type (2026-2033)
12.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Forecast by Application (2026-2033)
12.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) Forecast by Application
12.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Point-of-care Testing (POCT) for Substance Abuse
1.2 Key Market Segments
1.2.1 Point-of-care Testing (POCT) for Substance Abuse Segment by Type
1.2.2 Point-of-care Testing (POCT) for Substance Abuse Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Point-of-care Testing (POCT) for Substance Abuse Product Life Cycle
3.3 Global Point-of-care Testing (POCT) for Substance Abuse Sales by Manufacturers (2020-2025)
3.4 Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Manufacturers (2020-2025)
3.5 Point-of-care Testing (POCT) for Substance Abuse Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Point-of-care Testing (POCT) for Substance Abuse Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Point-of-care Testing (POCT) for Substance Abuse Market Competitive Situation and Trends
3.8.1 Point-of-care Testing (POCT) for Substance Abuse Market Concentration Rate
3.8.2 Global 5 and 10 Largest Point-of-care Testing (POCT) for Substance Abuse Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE INDUSTRY CHAIN ANALYSIS
4.1 Point-of-care Testing (POCT) for Substance Abuse Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Point-of-care Testing (POCT) for Substance Abuse Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Point-of-care Testing (POCT) for Substance Abuse Market
5.7 ESG Ratings of Leading Companies
6 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2020-2025)
6.3 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Type (2020-2025)
6.4 Global Point-of-care Testing (POCT) for Substance Abuse Price by Type (2020-2025)
7 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Sales by Application (2020-2025)
7.3 Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) by Application (2020-2025)
7.4 Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate by Application (2020-2025)
8 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET SALES BY REGION
8.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.1.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region
8.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region
8.3 North America
8.3.1 North America Point-of-care Testing (POCT) for Substance Abuse Sales by Country
8.3.2 North America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country
8.4.2 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.5.2 Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Point-of-care Testing (POCT) for Substance Abuse Sales by Country
8.6.2 South America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Region
8.7.2 Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET PRODUCTION BY REGION
9.1 Global Production of Point-of-care Testing (POCT) for Substance Abuse by Region(2020-2025)
9.2 Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2020-2025)
9.3 Global Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Point-of-care Testing (POCT) for Substance Abuse Production
9.4.1 North America Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.4.2 North America Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Point-of-care Testing (POCT) for Substance Abuse Production
9.5.1 Europe Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.5.2 Europe Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Point-of-care Testing (POCT) for Substance Abuse Production (2020-2025)
9.6.1 Japan Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.6.2 Japan Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Point-of-care Testing (POCT) for Substance Abuse Production (2020-2025)
9.7.1 China Point-of-care Testing (POCT) for Substance Abuse Production Growth Rate (2020-2025)
9.7.2 China Point-of-care Testing (POCT) for Substance Abuse Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Roche
10.1.1 Roche Basic Information
10.1.2 Roche Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.1.3 Roche Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.1.4 Roche Business Overview
10.1.5 Roche SWOT Analysis
10.1.6 Roche Recent Developments
10.2 Danaher
10.2.1 Danaher Basic Information
10.2.2 Danaher Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.2.3 Danaher Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.2.4 Danaher Business Overview
10.2.5 Danaher SWOT Analysis
10.2.6 Danaher Recent Developments
10.3 Abbott
10.3.1 Abbott Basic Information
10.3.2 Abbott Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.3.3 Abbott Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.3.4 Abbott Business Overview
10.3.5 Abbott SWOT Analysis
10.3.6 Abbott Recent Developments
10.4 Siemens
10.4.1 Siemens Basic Information
10.4.2 Siemens Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.4.3 Siemens Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.4.4 Siemens Business Overview
10.4.5 Siemens Recent Developments
10.5 Beijing Hotgen Biotech
10.5.1 Beijing Hotgen Biotech Basic Information
10.5.2 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.5.3 Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.5.4 Beijing Hotgen Biotech Business Overview
10.5.5 Beijing Hotgen Biotech Recent Developments
10.6 Hangzhou Biotest Biotech CO.,LTD
10.6.1 Hangzhou Biotest Biotech CO.,LTD Basic Information
10.6.2 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.6.3 Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.6.4 Hangzhou Biotest Biotech CO.,LTD Business Overview
10.6.5 Hangzhou Biotest Biotech CO.,LTD Recent Developments
10.7 Assure Tech
10.7.1 Assure Tech Basic Information
10.7.2 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.7.3 Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.7.4 Assure Tech Business Overview
10.7.5 Assure Tech Recent Developments
10.8 Orient Gene
10.8.1 Orient Gene Basic Information
10.8.2 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.8.3 Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.8.4 Orient Gene Business Overview
10.8.5 Orient Gene Recent Developments
10.9 Thermo Fisher
10.9.1 Thermo Fisher Basic Information
10.9.2 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.9.3 Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.9.4 Thermo Fisher Business Overview
10.9.5 Thermo Fisher Recent Developments
10.10 Guangzhou Wondfo Biotech Co.,Ltd.
10.10.1 Guangzhou Wondfo Biotech Co.,Ltd. Basic Information
10.10.2 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.10.3 Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.10.4 Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
10.10.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
10.11 Hangzhou Alltest Biotech Co.,Ltd.
10.11.1 Hangzhou Alltest Biotech Co.,Ltd. Basic Information
10.11.2 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.11.3 Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.11.4 Hangzhou Alltest Biotech Co.,Ltd. Business Overview
10.11.5 Hangzhou Alltest Biotech Co.,Ltd. Recent Developments
10.12 Beckman Coulter
10.12.1 Beckman Coulter Basic Information
10.12.2 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.12.3 Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.12.4 Beckman Coulter Business Overview
10.12.5 Beckman Coulter Recent Developments
10.13 Bio-Rad
10.13.1 Bio-Rad Basic Information
10.13.2 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.13.3 Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.13.4 Bio-Rad Business Overview
10.13.5 Bio-Rad Recent Developments
10.14 BioMerieux
10.14.1 BioMerieux Basic Information
10.14.2 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Overview
10.14.3 BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Market Performance
10.14.4 BioMerieux Business Overview
10.14.5 BioMerieux Recent Developments
11 POINT-OF-CARE TESTING (POCT) FOR SUBSTANCE ABUSE MARKET FORECAST BY REGION
11.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast
11.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country
11.2.3 Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region
11.2.4 South America Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Point-of-care Testing (POCT) for Substance Abuse by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Point-of-care Testing (POCT) for Substance Abuse Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Point-of-care Testing (POCT) for Substance Abuse by Type (2026-2033)
12.1.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Point-of-care Testing (POCT) for Substance Abuse by Type (2026-2033)
12.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Forecast by Application (2026-2033)
12.2.1 Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) Forecast by Application
12.2.2 Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Point-of-care Testing (POCT) for Substance Abuse Market Size Comparison by Region (M USD)
Table 5. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Substance Abuse as of 2024)
Table 10. Global Market Point-of-care Testing (POCT) for Substance Abuse Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Point-of-care Testing (POCT) for Substance Abuse Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Point-of-care Testing (POCT) for Substance Abuse Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Type (K Units)
Table 26. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Type (M USD)
Table 27. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Type (2020-2025)
Table 28. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2020-2025)
Table 29. Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) by Type (2020-2025)
Table 30. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Share by Type (2020-2025)
Table 31. Global Point-of-care Testing (POCT) for Substance Abuse Price (USD/Unit) by Type (2020-2025)
Table 32. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Application
Table 33. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Application
Table 34. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2020-2025) & (K Units)
Table 35. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2020-2025)
Table 36. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Application (2020-2025) & (M USD)
Table 37. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application (2020-2025)
Table 38. Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate by Application (2020-2025)
Table 39. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 40. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2020-2025)
Table 41. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (2020-2025) & (M USD)
Table 42. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region (2020-2025)
Table 43. North America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 44. North America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 46. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (2020-2025) & (M USD)
Table 49. South America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 50. South America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (2020-2025) & (M USD)
Table 53. Global Point-of-care Testing (POCT) for Substance Abuse Production (K Units) by Region(2020-2025)
Table 54. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2020-2025)
Table 56. Global Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Roche Basic Information
Table 62. Roche Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 63. Roche Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Roche Business Overview
Table 65. Roche SWOT Analysis
Table 66. Roche Recent Developments
Table 67. Danaher Basic Information
Table 68. Danaher Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 69. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Danaher Business Overview
Table 71. Danaher SWOT Analysis
Table 72. Danaher Recent Developments
Table 73. Abbott Basic Information
Table 74. Abbott Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 75. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Abbott Business Overview
Table 77. Abbott SWOT Analysis
Table 78. Abbott Recent Developments
Table 79. Siemens Basic Information
Table 80. Siemens Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 81. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Siemens Business Overview
Table 83. Siemens Recent Developments
Table 84. Beijing Hotgen Biotech Basic Information
Table 85. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 86. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Beijing Hotgen Biotech Business Overview
Table 88. Beijing Hotgen Biotech Recent Developments
Table 89. Hangzhou Biotest Biotech CO.,LTD Basic Information
Table 90. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 91. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Hangzhou Biotest Biotech CO.,LTD Business Overview
Table 93. Hangzhou Biotest Biotech CO.,LTD Recent Developments
Table 94. Assure Tech Basic Information
Table 95. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 96. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Assure Tech Business Overview
Table 98. Assure Tech Recent Developments
Table 99. Orient Gene Basic Information
Table 100. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 101. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Orient Gene Business Overview
Table 103. Orient Gene Recent Developments
Table 104. Thermo Fisher Basic Information
Table 105. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 106. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Thermo Fisher Business Overview
Table 108. Thermo Fisher Recent Developments
Table 109. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information
Table 110. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 111. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
Table 113. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
Table 114. Hangzhou Alltest Biotech Co.,Ltd. Basic Information
Table 115. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 116. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Hangzhou Alltest Biotech Co.,Ltd. Business Overview
Table 118. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments
Table 119. Beckman Coulter Basic Information
Table 120. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 121. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Beckman Coulter Business Overview
Table 123. Beckman Coulter Recent Developments
Table 124. Bio-Rad Basic Information
Table 125. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 126. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Bio-Rad Business Overview
Table 128. Bio-Rad Recent Developments
Table 129. BioMerieux Basic Information
Table 130. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 131. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. BioMerieux Business Overview
Table 133. BioMerieux Recent Developments
Table 134. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Point-of-care Testing (POCT) for Substance Abuse Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Point-of-care Testing (POCT) for Substance Abuse Market Size Comparison by Region (M USD)
Table 5. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Point-of-care Testing (POCT) for Substance Abuse as of 2024)
Table 10. Global Market Point-of-care Testing (POCT) for Substance Abuse Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Point-of-care Testing (POCT) for Substance Abuse Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Point-of-care Testing (POCT) for Substance Abuse Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Type (K Units)
Table 26. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Type (M USD)
Table 27. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Type (2020-2025)
Table 28. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Type (2020-2025)
Table 29. Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) by Type (2020-2025)
Table 30. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Share by Type (2020-2025)
Table 31. Global Point-of-care Testing (POCT) for Substance Abuse Price (USD/Unit) by Type (2020-2025)
Table 32. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) by Application
Table 33. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Application
Table 34. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Application (2020-2025) & (K Units)
Table 35. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2020-2025)
Table 36. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Application (2020-2025) & (M USD)
Table 37. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application (2020-2025)
Table 38. Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate by Application (2020-2025)
Table 39. Global Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 40. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2020-2025)
Table 41. Global Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (2020-2025) & (M USD)
Table 42. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region (2020-2025)
Table 43. North America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 44. North America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 46. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (2020-2025) & (M USD)
Table 49. South America Point-of-care Testing (POCT) for Substance Abuse Sales by Country (2020-2025) & (K Units)
Table 50. South America Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size by Region (2020-2025) & (M USD)
Table 53. Global Point-of-care Testing (POCT) for Substance Abuse Production (K Units) by Region(2020-2025)
Table 54. Global Point-of-care Testing (POCT) for Substance Abuse Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Market Share by Region (2020-2025)
Table 56. Global Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Point-of-care Testing (POCT) for Substance Abuse Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Roche Basic Information
Table 62. Roche Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 63. Roche Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Roche Business Overview
Table 65. Roche SWOT Analysis
Table 66. Roche Recent Developments
Table 67. Danaher Basic Information
Table 68. Danaher Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 69. Danaher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Danaher Business Overview
Table 71. Danaher SWOT Analysis
Table 72. Danaher Recent Developments
Table 73. Abbott Basic Information
Table 74. Abbott Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 75. Abbott Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Abbott Business Overview
Table 77. Abbott SWOT Analysis
Table 78. Abbott Recent Developments
Table 79. Siemens Basic Information
Table 80. Siemens Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 81. Siemens Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. Siemens Business Overview
Table 83. Siemens Recent Developments
Table 84. Beijing Hotgen Biotech Basic Information
Table 85. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 86. Beijing Hotgen Biotech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. Beijing Hotgen Biotech Business Overview
Table 88. Beijing Hotgen Biotech Recent Developments
Table 89. Hangzhou Biotest Biotech CO.,LTD Basic Information
Table 90. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 91. Hangzhou Biotest Biotech CO.,LTD Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. Hangzhou Biotest Biotech CO.,LTD Business Overview
Table 93. Hangzhou Biotest Biotech CO.,LTD Recent Developments
Table 94. Assure Tech Basic Information
Table 95. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 96. Assure Tech Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Assure Tech Business Overview
Table 98. Assure Tech Recent Developments
Table 99. Orient Gene Basic Information
Table 100. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 101. Orient Gene Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Orient Gene Business Overview
Table 103. Orient Gene Recent Developments
Table 104. Thermo Fisher Basic Information
Table 105. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 106. Thermo Fisher Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. Thermo Fisher Business Overview
Table 108. Thermo Fisher Recent Developments
Table 109. Guangzhou Wondfo Biotech Co.,Ltd. Basic Information
Table 110. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 111. Guangzhou Wondfo Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Guangzhou Wondfo Biotech Co.,Ltd. Business Overview
Table 113. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments
Table 114. Hangzhou Alltest Biotech Co.,Ltd. Basic Information
Table 115. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 116. Hangzhou Alltest Biotech Co.,Ltd. Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. Hangzhou Alltest Biotech Co.,Ltd. Business Overview
Table 118. Hangzhou Alltest Biotech Co.,Ltd. Recent Developments
Table 119. Beckman Coulter Basic Information
Table 120. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 121. Beckman Coulter Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Beckman Coulter Business Overview
Table 123. Beckman Coulter Recent Developments
Table 124. Bio-Rad Basic Information
Table 125. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 126. Bio-Rad Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Bio-Rad Business Overview
Table 128. Bio-Rad Recent Developments
Table 129. BioMerieux Basic Information
Table 130. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Product Overview
Table 131. BioMerieux Point-of-care Testing (POCT) for Substance Abuse Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. BioMerieux Business Overview
Table 133. BioMerieux Recent Developments
Table 134. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2026-2033) & (K Units)
Table 135. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region (2026-2033) & (M USD)
Table 136. North America Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (K Units)
Table 137. North America Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 138. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (K Units)
Table 139. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 140. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Region (2026-2033) & (K Units)
Table 141. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Region (2026-2033) & (M USD)
Table 142. South America Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (K Units)
Table 143. South America Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 144. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Country (2026-2033) & (Units)
Table 145. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Country (2026-2033) & (M USD)
Table 146. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Type (2026-2033) & (K Units)
Table 147. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Type (2026-2033) & (M USD)
Table 148. Global Point-of-care Testing (POCT) for Substance Abuse Price Forecast by Type (2026-2033) & (USD/Unit)
Table 149. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) Forecast by Application (2026-2033)
Table 150. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Point-of-care Testing (POCT) for Substance Abuse
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD), 2024-2033
Figure 5. Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) (2020-2033)
Figure 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Point-of-care Testing (POCT) for Substance Abuse Product Life Cycle
Figure 13. Point-of-care Testing (POCT) for Substance Abuse Sales Share by Manufacturers in 2024
Figure 14. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Share by Manufacturers in 2024
Figure 15. Point-of-care Testing (POCT) for Substance Abuse Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Point-of-care Testing (POCT) for Substance Abuse Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Point-of-care Testing (POCT) for Substance Abuse Revenue in 2024
Figure 18. Industry Chain Map of Point-of-care Testing (POCT) for Substance Abuse
Figure 19. Global Point-of-care Testing (POCT) for Substance Abuse Market PEST Analysis
Figure 20. Global Point-of-care Testing (POCT) for Substance Abuse Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Type
Figure 27. Sales Market Share of Point-of-care Testing (POCT) for Substance Abuse by Type (2020-2025)
Figure 28. Sales Market Share of Point-of-care Testing (POCT) for Substance Abuse by Type in 2024
Figure 29. Market Size Share of Point-of-care Testing (POCT) for Substance Abuse by Type (2020-2025)
Figure 30. Market Size Share of Point-of-care Testing (POCT) for Substance Abuse by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application
Figure 33. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2020-2025)
Figure 34. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application in 2024
Figure 35. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application (2020-2025)
Figure 36. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application in 2024
Figure 37. Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate by Application (2020-2025)
Figure 38. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2020-2025)
Figure 39. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region (2020-2025)
Figure 40. North America Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2024
Figure 43. North America Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Country in 2024
Figure 45. U.S. Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Point-of-care Testing (POCT) for Substance Abuse Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Point-of-care Testing (POCT) for Substance Abuse Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2024
Figure 53. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Country in 2024
Figure 55. Germany Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region in 2024
Figure 67. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region in 2024
Figure 68. China Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (K Units)
Figure 79. South America Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2024
Figure 80. South America Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (M USD)
Figure 81. South America Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Country in 2024
Figure 82. Brazil Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2020-2025)
Figure 103. North America Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 106. China Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Point-of-care Testing (POCT) for Substance Abuse Market Share Forecast by Type (2026-2033)
Figure 111. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Application (2026-2033)
Figure 112. Global Point-of-care Testing (POCT) for Substance Abuse Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Point-of-care Testing (POCT) for Substance Abuse
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD), 2024-2033
Figure 5. Global Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) (2020-2033)
Figure 6. Global Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Point-of-care Testing (POCT) for Substance Abuse Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Point-of-care Testing (POCT) for Substance Abuse Product Life Cycle
Figure 13. Point-of-care Testing (POCT) for Substance Abuse Sales Share by Manufacturers in 2024
Figure 14. Global Point-of-care Testing (POCT) for Substance Abuse Revenue Share by Manufacturers in 2024
Figure 15. Point-of-care Testing (POCT) for Substance Abuse Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Point-of-care Testing (POCT) for Substance Abuse Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Point-of-care Testing (POCT) for Substance Abuse Revenue in 2024
Figure 18. Industry Chain Map of Point-of-care Testing (POCT) for Substance Abuse
Figure 19. Global Point-of-care Testing (POCT) for Substance Abuse Market PEST Analysis
Figure 20. Global Point-of-care Testing (POCT) for Substance Abuse Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Type
Figure 27. Sales Market Share of Point-of-care Testing (POCT) for Substance Abuse by Type (2020-2025)
Figure 28. Sales Market Share of Point-of-care Testing (POCT) for Substance Abuse by Type in 2024
Figure 29. Market Size Share of Point-of-care Testing (POCT) for Substance Abuse by Type (2020-2025)
Figure 30. Market Size Share of Point-of-care Testing (POCT) for Substance Abuse by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application
Figure 33. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application (2020-2025)
Figure 34. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Application in 2024
Figure 35. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application (2020-2025)
Figure 36. Global Point-of-care Testing (POCT) for Substance Abuse Market Share by Application in 2024
Figure 37. Global Point-of-care Testing (POCT) for Substance Abuse Sales Growth Rate by Application (2020-2025)
Figure 38. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region (2020-2025)
Figure 39. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region (2020-2025)
Figure 40. North America Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2024
Figure 43. North America Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Country in 2024
Figure 45. U.S. Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Point-of-care Testing (POCT) for Substance Abuse Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Point-of-care Testing (POCT) for Substance Abuse Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Point-of-care Testing (POCT) for Substance Abuse Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Point-of-care Testing (POCT) for Substance Abuse Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2024
Figure 53. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Country in 2024
Figure 55. Germany Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region in 2024
Figure 67. Asia Pacific Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region in 2024
Figure 68. China Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (K Units)
Figure 79. South America Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Country in 2024
Figure 80. South America Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (M USD)
Figure 81. South America Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Country in 2024
Figure 82. Brazil Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Point-of-care Testing (POCT) for Substance Abuse Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Point-of-care Testing (POCT) for Substance Abuse Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Point-of-care Testing (POCT) for Substance Abuse Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Point-of-care Testing (POCT) for Substance Abuse Production Market Share by Region (2020-2025)
Figure 103. North America Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 106. China Point-of-care Testing (POCT) for Substance Abuse Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Point-of-care Testing (POCT) for Substance Abuse Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Point-of-care Testing (POCT) for Substance Abuse Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Point-of-care Testing (POCT) for Substance Abuse Market Share Forecast by Type (2026-2033)
Figure 111. Global Point-of-care Testing (POCT) for Substance Abuse Sales Forecast by Application (2026-2033)
Figure 112. Global Point-of-care Testing (POCT) for Substance Abuse Market Share Forecast by Application (2026-2033)
